|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61P 1/04 | (2006.01) | ||
| C07K 16/24 | (2006.01) |
| (11) | Number of the document | 4327866 |
| (13) | Kind of document | T |
| (96) | European patent application number | 23215626.5 |
| Date of filing the European patent application | 2019-03-28 | |
| (97) | Date of publication of the European application | 2024-02-28 |
| (45) | Date of publication and mention of the grant of the patent | 2025-12-10 |
| (46) | Date of publication of the claims translation | 2026-03-10 |
| (30) | Number | Date | Country code |
| 201862650314 P | 2018-03-30 | US |
| (72) |
CANAVAN, James Benedict , US
FRIEDRICH, Stuart William , US
KRUEGER, Kathryn Ann , US
MILCH, Catherine , US
TUTTLE, Jay Lawrence , US
|
| (73) |
Eli Lilly and Company ,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Jelena GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Mirikizumabas opinio kolito gydymui |
| MIRIKIZUMAB IN THE TREATMENT OF ULCERATIVE COLITIS |
| Payment date | Validity (years) | Amount | |
| 2026-02-19 | 8 | 185.00 EUR |
| 2027-03-28 |